Genovate Biotechnology Co., Ltd. (TPEX:4130)

Genovate Biotechnology Revenue

Genovate Biotechnology had revenue of 110.38M TWD in the quarter ending March 31, 2026, a decrease of -15.93%. This brings the company's revenue in the last twelve months to 471.48M, down -6.23% year-over-year. In the year 2025, Genovate Biotechnology had annual revenue of 492.41M, down -3.61%.

• Revenue (ttm): 471.48M
• Revenue Growth: -6.23%
• P/S Ratio: 6.42
• Revenue / Employee: 2.48M
• Employees: 190
• Market Cap: 3.03B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	492.41M	-18.45M	-3.61%
Dec 31, 2024	510.86M	-17.66M	-3.34%
Dec 31, 2023	528.51M	89.75M	20.46%
Dec 31, 2022	438.76M	4.51M	1.04%
Dec 31, 2021	434.25M	-38.47M	-8.14%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 29, 2026

Data Sources Report a data error